1. Home
  2. ITOS vs ANIK Comparison

ITOS vs ANIK Comparison

Compare ITOS & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • ANIK
  • Stock Information
  • Founded
  • ITOS 2011
  • ANIK 1983
  • Country
  • ITOS United States
  • ANIK United States
  • Employees
  • ITOS N/A
  • ANIK N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • ANIK Medical/Dental Instruments
  • Sector
  • ITOS Health Care
  • ANIK Health Care
  • Exchange
  • ITOS Nasdaq
  • ANIK Nasdaq
  • Market Cap
  • ITOS 270.7M
  • ANIK 243.4M
  • IPO Year
  • ITOS 2020
  • ANIK 1993
  • Fundamental
  • Price
  • ITOS $7.19
  • ANIK $15.21
  • Analyst Decision
  • ITOS Strong Buy
  • ANIK Buy
  • Analyst Count
  • ITOS 3
  • ANIK 2
  • Target Price
  • ITOS $26.00
  • ANIK $22.00
  • AVG Volume (30 Days)
  • ITOS 334.2K
  • ANIK 74.7K
  • Earning Date
  • ITOS 03-05-2025
  • ANIK 03-12-2025
  • Dividend Yield
  • ITOS N/A
  • ANIK N/A
  • EPS Growth
  • ITOS N/A
  • ANIK N/A
  • EPS
  • ITOS N/A
  • ANIK N/A
  • Revenue
  • ITOS $35,000,000.00
  • ANIK $119,907,000.00
  • Revenue This Year
  • ITOS N/A
  • ANIK N/A
  • Revenue Next Year
  • ITOS $121.70
  • ANIK $8.50
  • P/E Ratio
  • ITOS N/A
  • ANIK N/A
  • Revenue Growth
  • ITOS 177.89
  • ANIK N/A
  • 52 Week Low
  • ITOS $6.67
  • ANIK $14.95
  • 52 Week High
  • ITOS $18.75
  • ANIK $29.12
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 48.18
  • ANIK 28.17
  • Support Level
  • ITOS $6.73
  • ANIK $16.75
  • Resistance Level
  • ITOS $7.32
  • ANIK $17.14
  • Average True Range (ATR)
  • ITOS 0.38
  • ANIK 0.71
  • MACD
  • ITOS 0.03
  • ANIK -0.19
  • Stochastic Oscillator
  • ITOS 53.06
  • ANIK 8.33

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: